were introduced, and systematic fluorine, bromine, and phenyl scans for phenylalanine in the P2 position were performed. Moreover, the N-terminal protection was varied. Kinetic investigations were carried out with cathepsin L, S, and K as well as papain. Changes in the backbone structure of the parent N-(tert-butoxycarbonyl)-phenylalanyl-glycine-nitrile (16), such as the introduction of an R-configured
[EN] PEPTIDASE INHIBITORS<br/>[FR] INHIBITEURS DE PEPTIDASE
申请人:PROZYMEX AS
公开号:WO2012130299A1
公开(公告)日:2012-10-04
Novel compounds of the formula (I) wherein R1, R2, D, A, B and X have the meanings defined herein, pharmaceutical compositions comprising them as active ingredient, as well as their use in medicine, in particular as peptidase inhibitors, more specifically inhibitors of cysteine and/or serine peptidases useful in the treatment/prevention of inflammatory diseases.
The present invention relates to compounds of the formula
which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
Compounds are provided for use with glucokinase that comprise the formula:
wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Off the menu: We report a new, very strong feedingdeterrentagainstantsreleased by larvae of the alderleafbeetleAgelasticaalni when attacked. The major deterrent component proved to be γ‐L‐glutamyl‐L‐2‐furylalanine, a novel dipeptide containing the unusual amino acid L‐2‐furylalanine, which, although synthetically well known, has not previously been reported from natural sources.